Zevra Therapeutics, Inc. (ZVRA) Operating cash flow 2016–2025
Zevra Therapeutics, Inc. (ZVRA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$1.6MFY2025 · since FY2016: -$29.8M → -$1.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$1.6M | +97.7% |
| FY2024 | -$69.7M | -107.7% |
| FY2023 | -$33.5M | -79.2% |
| FY2022 | -$18.7M | -279.3% |
| FY2021 | $10.4M | +638.4% |
| FY2020 | -$1.9M | +91.8% |
| FY2019 | -$23.7M | +56.2% |
| FY2018 | -$54.2M | -63.8% |
| FY2017 | -$33.1M | -11.2% |
| FY2016 | -$29.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice